Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06316739 · ClinicalTrials.gov registry record · NA
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
A NA study of HIV Infections and Overdose, sponsored by North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI).
- Active
- Registry status
- NA
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT06316739 is a NA study of HIV Infections and Overdose that is active but no longer recruiting, run by North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI). The registered enrollment target is 69 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06316739, a NA study of HIV Infections and Overdose, is active but no longer recruiting, sponsored by North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot clinical trial is to learn if an intervention that trains Gancheros (people who provide injection services in exchange for drugs or money) to conduct risk-reduction outreach could help lower risk for human immunodeficiency virus (HIV), hepatitis C virus (HCV) and overdose among migrant Puerto Rican people who inject drugs (PWID) in New York City. The main questions it aims to answer are: * Can the Ganchero intervention be carried out successfully and will Gancheros and their clients like it? * Could the Ganchero intervention help Puerto Rican PWID who are clients of Gancheros use sterile syringes and carry naloxone (a medication to reverse opioid overdoses) more often? Gancheros who participate in the trial will be asked to attend a 6-session training on HIV, HCV, and overdose prevention and then to share key prevention messages and supplies (e.g., naloxone, sterile syringes and other injection equipment) with their clients during 4 months of outreach. The intervention will be carried out with Gancheros and their clients in two Bronx neighborhoods, one after the other, so the investigators can see if clients in the neighborhood that received the intervention first have better outcomes than clients in the neighborhood that did not yet receive the intervention.
Conditions Studied
Interventions
- BEHAVIORAL Ganchero intervention
Study Locations (1)
New York
- CUNY Graduate School of Public Health & Health Policy - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2025-11-01 |
| Phase | NA |
Sponsor
North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI)1 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06316739
The ClinicalTrials.gov registry entry for NCT06316739 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (85% lower). The listed sponsor is North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI), which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Ganchero intervention is the first listed.
NCT06316739 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06316739 about?
NCT06316739 is a clinical study titled "The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City". The goal of this pilot clinical trial is to learn if an intervention that trains Gancheros (people who provide injection services in exchange for drugs or money) to conduct risk-reduction outreach could help lower risk for human immunodeficiency virus (HIV), hepatitis C virus (HCV) and overdose amon...
What is the current status of trial NCT06316739?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 69 participants. The study started on 2024-05-01. Estimated completion is 2025-11-01.
What conditions does trial NCT06316739 study?
This clinical trial studies the following conditions: HIV Infections, Overdose, HCV.
What interventions are being tested in trial NCT06316739?
The interventions under investigation include: Ganchero intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06316739?
This trial is sponsored by North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06316739 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.